Skip to main content
. Author manuscript; available in PMC: 2010 Sep 15.
Published in final edited form as: Clin Infect Dis. 2009 Sep 15;49(6):956–964. doi: 10.1086/605503

Table 2.

Clinical/immunogenetic biomarkers and rates of CD4 decline: Bi-Variate analyses.

Biomarker Group Frequency (%) CD4 cell decline (cells/mm3 per year) p-value
Primary Analysis: biomarkers as binary variables
Baseline CD4 >350 186 (62) −39.9 <0.0001
201–350 114 (38) −19.3
pVL >100,000 107 (36) −51.8 <0.0001
≤100,000 193 (64) −28.1
HLA Non-protective 184 (61) −40 0.0002
protective 116 (39) −27.2